Investors

FSD is a specialty, biotech pharmaceutical R&D company that aims to deliver growth and returns to shareholders through the development of innovative pharmaceutical products that target the human endocannabinoid system.

Shareholder Information

COMPANY INFORMATION

Legal Counsel
Bennet Jones, LLP

Auditor
MNP LLP

Fiscal Year End
December 31

Jurisdiction
Ontario, Canada

Transfer Agent
Computershare Trust Corporation

CLASS A SHARES – ISSUED & OUTSTANDING

72

CLASS B SUBORDINATE VOTING SHARES

CUSIP
35954B206

ISIN
CA35954B2066

Capital Structure – Issued & Outstanding Basic
7,905,727

Capital Structure – Issued & Outstanding Fully Diluted
9,516,008

CORPORATE GOVERNANCE

Code of Conduct and Ethics

CSE Symbol:

Class B Subordinate Voting Shares

HUGE

Investor Contact Details

The FSD investor relations team responds to requests from professional members of the financial community.

[email protected]

Events & Presentations

Annual General Meeting

Date: Monday December 16, 2019
Time: 10:00 a.m. Eastern
Location: Bennett Jones LLP, 100 King Street West, First Canadian Place, Suite 3400, M5X 1A4

12th Annual LD Micro Main Event Investor Conference

Date: Wednesday December 11, 2019
Time: 12:20 pm PT/3:30 pm ET
Location: Luxe Sunset Boulevard Hotel, Los Angeles
Presenter: Dr. Edward Brennan, President, BioSciences Division

Investor Summit

Date: December 17, 2019
Time: 2:35 pm ET
Location: Kimpton Hotel Monaco, Philadelphia
Presenter: Dr. Raza Bokhari, Executive Co-Chairman and Chief Executive Officer
Webcast (live and archived for 1 year): https://www.webcaster4.com/Webcast/Page/2038/32606